Search the Site
join our mailing list
subscriber login
.jpg)
PO Box 9905
Washington
DC 20016
| ISSUE 24 - June 17, 2016 |
Moonshot May Play Role in $400 Million Annual Contract to Run NCI's Frederick Lab
The contract for operations and technical support at the Frederick National Laboratory for Cancer Research could be accepting proposals as early as next month—but NCI advisors said they are hoping to slow the recompetition process to reform the laboratory’s mission.
Moreover, NCI should consider how the laboratory could contribute to Vice President Joe Biden’s National Cancer Moonshot Initiative, members of the Frederick National Laboratory Advisory Committee said at a recent meeting.
 |
Task Force Adds Tests to Colon Screening GuidelineThe final version of guidelines for colorectal cancer screening by the U.S. Preventive Services Task Force differ substantively from the group’s draft version published last October. The final version—unlike the draft—lists CT colonography and FIT-DNA as screening methods that are equal to others. It’s unclear whether political pressure had any role in prompting the panel to broaden its list of detection strategies from three to seven in the past six months. |
 |
Conversation with The Cancer LetterGuideline Edits Rooted in Science, Former USPSTF Member Says"I don’t see this recommendation as differing in any substantial way from some others that we’ve made, where we suggested that patients talk with their clinicians, and the important messages here is that colorectal cancer screening works, that colorectal cancer screening reduces deaths from colorectal cancer,” said Douglas Owens, a who has rotated off the U.S. Preventive Services Task Force, and was involved in developing the colorectal cancer screening guideline published earlier this week. |
 |
In Brief
|
 |
Drugs and Targets
|
